AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
1.230
+0.175 (16.59%)
Feb 5, 2026, 2:13 PM EST - Market open

AIM ImmunoTech Revenue

AIM ImmunoTech had revenue of $26.00K in the quarter ending September 30, 2025, a decrease of -25.71%. This brings the company's revenue in the last twelve months to $112.00K, down -41.05% year-over-year. In the year 2024, AIM ImmunoTech had annual revenue of $170.00K, down -15.84%.

Revenue (ttm)
$112.00K
Revenue Growth
-41.05%
P/S Ratio
9.96
Revenue / Employee
$4,870
Employees
23
Market Cap
3.51M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024170.00K-32.00K-15.84%
Dec 31, 2023202.00K61.00K43.26%
Dec 31, 2022141.00K6.00K4.44%
Dec 31, 2021135.00K-28.00K-17.18%
Dec 31, 2020163.00K23.00K16.43%
Dec 31, 2019140.00K-227.00K-61.85%
Dec 31, 2018367.00K-70.00K-16.02%
Dec 31, 2017437.00K345.00K375.00%
Dec 31, 201692.00K-41.00K-30.83%
Dec 31, 2015133.00K-64.00K-32.49%
Dec 31, 2014197.00K47.00K31.33%
Dec 31, 2013150.00K-63.00K-29.58%
Dec 31, 2012213.00K52.00K32.30%
Dec 31, 2011161.00K26.00K19.26%
Dec 31, 2010135.00K24.00K21.62%
Dec 31, 2009111.00K-154.00K-58.11%
Dec 31, 2008265.00K-794.00K-74.98%
Dec 31, 20071.06M126.00K13.50%
Dec 31, 2006933.00K-150.00K-13.85%
Dec 31, 20051.08M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jaguar Health11.79M
SciSparc1.31M
Scinai Immunotherapeutics1.15M
Lyra Therapeutics600.00K
HCW Biologics422.03K
Revenue Rankings